HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,830.00
+30.00 (0.44%)
Nov 17, 2026, 3:30 PM KST

HLB Pharmaceutical Market Cap

HLB Pharmaceutical has a market cap or net worth of 224.02 billion as of November 16, 2026. It is the 21,379th most valuable company in the world and the 712th biggest in South Korea. Its market cap has decreased by 4.01% in one year.

Market Cap
224.02B
Enterprise Value
168.85B
Revenue
253.85B
Global Rank
Country Rank
#712 South Korea
PE Ratio
68.06

Chart

Chart

Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 224.02B, an increase of 165.80%. That is a compound annual growth rate of 9.37%.

History

DateMarket Cap% Change
Nov 17, 2026224.02B-0.54%
Dec 30, 2025225.24B-33.44%
Dec 30, 2024338.42B58.45%
Dec 28, 2023213.58B43.49%
Dec 29, 2022148.85B-21.48%
Dec 30, 2021189.57B-21.05%
Dec 30, 2020 Pro Pro
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

CompanyMarket Cap
JW Holdings253.58B
Samjin Pharmaceuticals245.16B
Humedix233.75B
Korea United Pharm220.35B
Whan In Pharm198.33B
Huons179.90B
Suheung179.07B
REYON Pharmaceutical174.42B
Market Cap Rankings